Nice to see the Gretchen Morgenson of the New York Times writing about my appeal of the SEC’s no-action letter allowing Whole Foods Market to exclude my proxy access proposal. (Whole Foods’ High Hurdle for Investors, 1/3/2015) As Morgenson, writes: (more…)
Boston Scientific Corp., which posted a $1.6 billion first-quarter loss, is on probation for concealment of safety defects in its heart defibrillators earlier in the decade and is faces charges of overpaying its CEO, is barring media from its shareholders meeting tomorrow morning. Beth Young, of the Corporate Library said, I think it’s not the […]